Riskpilot← Back to searchSign inGet full accessROTOBED ApS
APSActiveCVR 25589580Storegade 44Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20137 employeeswww.rotobed.com
Revenue 2024
DKK 3,7M
-8% vs 2023
EBITDA margin
36.5%
-16% vs 2023
Equity ratio
41.4%
Financial strength
Net profit 2024
DKK 301K
-43% vs 2023
| Revenue | DKK 3,7M | -8% |
| EBITDA | DKK 1,3M | -16% |
| Net profit | DKK 301K | -43% |
| Total assets | DKK 10,5M | -13% |
| Equity | DKK 4,3M | +7% |
| Employees | 7 | — |
Legal name
ROTOBED ApS
CVR number
25589580
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
16. december 2013
Share capital
DKK 80.000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at virke som globalt salgs- og distributionsselskab af plejesenge og andre hjælpemidler.
Address
Storegade 44
Phone
+4575505025
Email
info@rotobed.com
Website
www.rotobed.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3.268 | 5.389 | 3.015 | 4.041 | 3.701 |
| Staff expenses | -2.261 | -2.304 | -2.018 | -2.435 | -2.351 |
| EBITDA | 1.007 | 3.085 | 997 | 1.606 | 1.350 |
| Depreciation & amort. | -346 | -366 | -696 | -472 | -603 |
| EBIT | 661 | 2.719 | 301 | 1.133 | 747 |
| Net financials | -255 | -160 | -229 | -439 | -344 |
| Profit before tax | 407 | 2.559 | 72 | 694 | 403 |
| Tax | 73 | 544 | -10 | 164 | 102 |
| Net profit | 333 | 2.015 | 82 | 530 | 301 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 11.305 | 13.677 | 12.429 | 12.088 | 10.488 |
| Equity | 1.412 | 3.427 | 3.508 | 4.039 | 4.340 |
| Long-term debt | 116 | 118 | 120 | 123 | 127 |
| Short-term debt | 9.385 | 9.720 | 8.426 | 7.633 | 5.854 |
| Total debt | 9.501 | 9.838 | 8.546 | 7.756 | 5.980 |
EBITDA margin
36.5%
This company
15.8%
Market median
+131% vs market
20202024
Equity ratio
41.4%
This company
38.2%
Market median
+8% vs market
20202024
Return on equity
6.9%
This company
18.4%
Market median
-63% vs market
20202024
Net profit margin
8.1%
This company
8.1%
Market median
+0% vs market
20202024
Asset turnover
0.35×
This company
1.12×
Market median
-69% vs market
20202024
Debt / equity
1.42×
This company
0.62×
Market median
-129% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MR Management | Management | 2013 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2016 | |
| Individual | 10–14.99% | 10–14.99% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Holdingselskabet af 21.04.2008 ApS
ROTOBED ApS Board members of ROTOBED ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Riis Holm | Management | 0 companies |